NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.

Cancer
Seth M PollackCassian Yee

Abstract

Myxoid/round cell liposarcoma (MRCL) is the second most common liposarcoma subtype, accounting for >33% of liposarcomas and approximately 10% of all soft tissue sarcomas. Although MRCL is a chemosensitive subtype, patients with metastatic disease have a poor outcome. NY-ESO-1 is a cancer-testis antigen (also known as cancer germ cell antigen) that has been successfully targeted in vaccine trials and in adoptive T-cell therapy trials for the treatment of several solid tumors. The authors investigated the feasibility of targeting NY-ESO-1 in patients with MRCL by evaluating the prevalence of NY-ESO-1 expression in tumors using immunohistochemistry and quantitative reverse transcriptase-polymerase chain reaction analysis. NY-ESO-1-specific tumor recognition by NY-ESO-1-specific T-cells also was analyzed using a chromium release assay. A search of the University of Washington Sarcoma Tissue Bank identified paraffin-embedded tumor samples from 25 patients with MRCL. NY-ESO-1 expression was observed in every MRCL tumor assessed (100%); in 18 tumors (72%), staining was homogenous. In all but 2 tumors, staining was sufficiently robust (2+) that such patients would be eligible for clinical trials of NY-ESO-1-directed therapy. By using N...Continue Reading

References

Apr 17, 1990·Journal of Immunological Methods·S R Riddell, P D Greenberg
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y T ChenL J Old
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·M NagaiK Nagashima
May 15, 2001·International Journal of Cancer. Journal International Du Cancer·A A JungbluthL J Old
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·A A JungbluthL J Old
Apr 17, 2002·Human Pathology·Cristina R AntonescuAchim A Jungbluth
Jan 10, 2003·Nucleic Acids Research·Filip PattynJo Vandesompele
Feb 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Sang-Yull LeeMatthew J Scanlan
Jul 24, 2003·The American Journal of Pathology·Neil H SegalCarlos Cordon-Cardo
Jul 15, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ian D DavisJonathan S Cebon
Dec 30, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hilary A VaughanJonathan Cebon
Apr 9, 2005·Cancer Investigation·Keith M SkubitzAmy P N Skubitz
Nov 18, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Robin L JonesIan R Judson
Sep 21, 2006·Proceedings of the National Academy of Sciences of the United States of America·Elke JägerAlexander Knuth
Oct 5, 2006·International Journal of Cancer. Journal International Du Cancer·Joannes F M JacobsI Jolanda M de Vries
May 8, 2008·Journal of Translational Medicine·Keith M SkubitzAmy P N Skubitz
Jun 21, 2008·The New England Journal of Medicine·Naomi N HunderCassian Yee
Mar 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Theo NicholaouJonathan Cebon
Aug 18, 2010·International Journal of Cancer. Journal International Du Cancer·Cyril CuffelDonata Rimoldi
Aug 25, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roberta FrapolliMaurizio D'Incalci
Feb 2, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul F RobbinsSteven A Rosenberg
Nov 15, 2011·Nature Structural & Molecular Biology·Jessica I HoellThomas Tuschl

❮ Previous
Next ❯

Citations

Apr 20, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jessica A Hemminger, O Hans Iwenofu
Jan 25, 2014·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jessica A HemmingerO Hans Iwenofu
Nov 27, 2014·Archives of Pathology & Laboratory Medicine·Fan Lin, Haiyan Liu
Dec 18, 2014·Expert Opinion on Biological Therapy·Giulia MesianoDario Sangiolo
Oct 16, 2014·Journal for Immunotherapy of Cancer·Seth M PollackCassian Yee
Apr 30, 2014·Sarcoma·S P D'AngeloR D Carvajal
Aug 9, 2016·The Journal of Pathology. Clinical Research·Kunio IuraYoshinao Oda
May 16, 2015·Current Treatment Options in Oncology·Melissa Burgess, Hussein Tawbi
Jan 28, 2015·Human Vaccines & Immunotherapeutics·William W TsengEdgar G Engleman
Apr 29, 2015·Immunotherapy·Ali Esfandiary, Soudeh Ghafouri-Fard
Nov 22, 2014·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Makoto EndoTorsten O Nielsen
Dec 31, 2014·Archives of Pathology & Laboratory Medicine·George Lin, Leona A Doyle
Jun 9, 2016·Laboratory Investigation; a Journal of Technical Methods and Pathology·Marieke A de GraaffNeeta Somaiah
Sep 8, 2016·Immunological Investigations·Arash SalmaninejadNima Rezaei
Oct 6, 2016·Sarcoma·Demytra MitsisJoseph Skitzki
Sep 8, 2016·JBJS Reviews·Rosanna WustrackKristy Weber
Feb 1, 2017·Expert Review of Clinical Pharmacology·Maristella SaponaraAlessandro Gronchi
Mar 11, 2016·Journal of Oncology Practice·Gulam A Manji, Gary K Schwartz
Apr 21, 2017·Expert Review of Anticancer Therapy·E SkafidaA Digklia
Nov 20, 2018·F1000Research·Jennifer Choe, Richard Riedel
Oct 27, 2018·Current Treatment Options in Oncology·Sarah Abaricia, Angela C Hirbe
Sep 1, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jessica A HemmingerO Hans Iwenofu
Dec 18, 2013·Internal Medicine·Takehiro OkabayashiMasanori Morita
Jan 9, 2014·Expert Review of Anticancer Therapy·Attila Kollár, Charlotte Benson
Aug 2, 2017·Pathology International·Yoshinao OdaHirofumi Bekki
Dec 9, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Seth M PollackGary K Schwartz
Dec 9, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alex Thomas John LeeRobin Lewis Jones
Apr 5, 2020·Veterinary and Comparative Oncology·Matthew J AthertonNicola J Mason
Jun 2, 2016·American Society of Clinical Oncology Educational Book·Alex LeeSeth M Pollack
Sep 25, 2015·International Journal of Surgical Pathology·Jonathan NoujaimRobin L Jones
Sep 25, 2017·The Oncologist·Michael J NathensonEdward Sausville
Sep 21, 2018·American Society of Clinical Oncology Educational Book·Daniela KatzSeth M Pollack
Dec 24, 2018·Cancers·Alexandra PenderSeth Pollack
May 29, 2019·Expert Opinion on Pharmacotherapy·Lorena P Suarez-KellyAlessandro Gronchi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.